Short-term outcomes in patients with center-involving diabetic macular edema after a single dose of intravitreal bevacizumab.
Christopher A TurskiMitchell A JacobsMichelle M Abou-JaoudeNicholas H FowlerRyan HarpoleEmily AltmanJohn B ChadwellGabriel KindlHayley R JamesShivani V ReddyMaldonado Ramiro SPublished in: International journal of retina and vitreous (2022)
The short-term response to a single IVB was sub-optimal with structural but no functional improvements. Greater baseline CST, presence of INL cysts and subretinal fluid may represent factors indicative of a better treatment response.